Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. TransMedics Group's annualizedGross Profit for the quarter that ended in Dec. 2023 was $191.7 Mil.
TransMedics Group's average Total Assets over the quarter that ended in Dec. 2023 was $697.6 Mil. Therefore, TransMedics Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 27.48%.
TransMedics Group Gross-Profit-to-Asset % Historical Data
The historical data trend for TransMedics Group's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, TransMedics Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group Gross-Profit-to-Asset % Distribution
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where TransMedics Group's Gross-Profit-to-Asset % falls into.
TransMedics Group Gross-Profit-to-Asset % Calculation
TransMedics Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
TransMedics Group Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of TransMedics Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
TransMedics Group (TransMedics Group) Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMDX has been successfully added to your 